Term: Anatomical Therapeutic Chemical (ATC) Drug Classification System

Glossary Definition

Last Updated: 2013-10-30

Definition:

A drug classification system widely used for research purposes. The drugs are divided into different groups at five levels according to the organ or system on which they act and/or therapeutic and chemical characteristics:

anatomical group;
therapeutic main group;
therapeutic/pharmacological subgroup;
chemical/therapeutic/pharmacological subgroup; and
subgroup for chemical substance.

ATC classifications are available online from the World Health Organization (WHO), and are updated and published once a year by the WHO Collaborating Centre for Drug Statistics Methodology. See the WHO On-line ATC / DDD Index: http://www.whocc.no/atc_ddd_index/ .

The ATC Drug Classification system is a component of the Health Canada Drug Product Database. See the Health Canada Web Site on the Drug Product Database (DPD): http://www.hc-sc.gc.ca/dhp-mps/prodpharma/databasdon/index-eng.php for more information.

Related concepts

Related terms

References

World Health Organization (WHO). W.H.O.'s Collaborating centre for drug statistics methodology: Guidelines for ATC classification and DDD assignment. Oslo, Norway: 1996.(View)

Term used in

Brownell M, Chartier M, Santos R, Ekuma O, Au W, Sarkar J, MacWilliam L, Burland E, Koseva I, Guenette W. How are Manitoba's Children Doing? Winnipeg, MB: Manitoba Centre for Health Policy, 2012. [Report] [Summary] [Updates and Errata] [Additional Materials] (View)
Doupe M, Brownell M, Kozyrskyj A, Dik N, Burchill C, Dahl M, Chateau D, De Coster C, Hinds A, Bodnarchuk J. Using Administrative Data to Develop Indicators of Quality Care in Personal Care Homes. Winnipeg, MB: Manitoba Centre for Health Policy, 2006. [Report] [Summary] [Additional Materials] (View)
Fransoo R, Martens P, Prior H, Chateau D, McDougall C, Schultz J, McGowan K, Soodeen R, Bailly A. Adult Obesity in Manitoba: Prevalence, Associations, and Outcomes. Winnipeg, MB: Manitoba Centre for Health Policy, 2011. [Report] [Summary] (View)
Fransoo R, Martens P, Burland E, The Need to Know Team, Prior H, Burchill C. Manitoba RHA Indicators Atlas 2009. Winnipeg, MB: Manitoba Centre for Health Policy, 2009. [Report] [Summary] [Additional Materials] (View)
Fransoo R, Martens P, The Need to Know Team, Burland E, Prior H, Burchill C, Chateau D, Walld R. Sex Differences in Health Status, Health Care Use, and Quality of Care: A Population-Based Analysis for Manitoba's Regional Health Authorities. Winnipeg, MB: Manitoba Centre for Health Policy, 2005. [Report] [Summary] [Additional Materials] (View)
Fransoo R, Martens P, The Need to Know Team, Prior H, Burchill C, Koseva I, Bailly A, Allegro E. The 2013 RHA Indicators Atlas. Winnipeg, MB: Manitoba Centre for Health Policy, 2013. [Report] [Summary] [Additional Materials] (View)
Katz A, Martens P, Chateau D, Bogdanovic B, Koseva I, McDougall C, Boriskewich E. Understanding the Health System Use of Ambulatory Care Patients. Winnipeg, MB: Manitoba Centre for Health Policy, 2013. [Report] [Summary] (View)
Kozyrskyj A, Raymond C, Dahl M, Ekuma O, Schultz J, Sklepowich M, Bond R. Effects of Manitoba Pharmacare Formulary Policy on Utilization of Prescription Medications. Winnipeg, MB: Manitoba Centre for Health Policy, 2009. [Report] [Summary] (View)
Lix L, Smith M, Pitz M, Ahmed R, Quon H, Griffith J, Turner D, Hong S, Prior H, Banerjee A, Koseva I, Kulbaba C. Cancer Data Linkage in Manitoba: Expanding the Infrastructure for Research. Winnipeg, MB: Manitoba Centre for Health Policy, 2016. [Report] [Summary] (View)
Lix L, Yogendran M, Burchill C, Metge C, McKeen N, Moore D, Bond R. Defining and Validating Chronic Diseases: An Administrative Data Approach. Winnipeg, MB: Manitoba Centre for Health Policy, 2006. [Report] [Summary] (View)
Martens P, Nickel N, Forget E, Lix L, Turner D, Prior H, Walld R, Soodeen RA, Rajotte L, Ekuma O. The Cost of Smoking: A Manitoba Study. Winnipeg, MB: Manitoba Centre for Health Policy, 2015. [Report] [Summary] [Updates and Errata] [Additional Materials] (View)
Martens P, Fransoo R, The Need to Know Team, Burland E, Prior H, Burchill C, Romphf L, Chateau D, Bailly A, Ouelette C. What Works? A First Look at Evaluating Manitoba's Regional Health Programs and Policies at the Population Level. Winnipeg, MB: Manitoba Centre for Health Policy, 2008. [Report] [Summary] [Additional Materials] (View)
Martens PJ, Bartlett J, Burland E, Prior H, Burchill C, Huq S, Romphf L, Sanguins J, Carter S, Bailly A. Profile of Metis Health Status and Healthcare Utilization in Manitoba: A Population-Based Study. Winnipeg, MB: Manitoba Centre for Health Policy, 2010. [Report] [Summary] [Updates and Errata] [Additional Materials] (View)
Metge C, Black C, Peterson S, Kozyrskyj A, Roos NP, Bogdanovic B. Analysis of Patterns of Pharmaceutical Use in Manitoba, 1996: Key Findings - A POPULIS Project. Winnipeg, MB: Manitoba Centre for Health Policy and Evaluation, 1999. [Report] [Summary] (View)
Metge C, Kozyrskyj A, Dahl M, Yogendran M, Roos NP. Pharmaceuticals: Focussing on Appropriate Utilization. Winnipeg, MB: Manitoba Centre for Health Policy, 2003. [Report] [Summary] (View)
Morgan SG, Kozyrskyj A, Metge C, Roos NP. Pharmaceuticals: Therapeutic interchange and pricing policies. Winnipeg, MB: Manitoba Centre for Health Policy, 2003. [Report] [Summary] (View)
Raymond C, Metge C, Alessi-Severini S, Dahl M, Schultz J, Guenette W. Pharmaceutical Use in Manitoba: Opportunities to Optimize Use. Winnipeg, MB: Manitoba Centre for Health Policy, 2010. [Report] [Summary] (View)